RayMed Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $300K

  • Investors
  • 1

RayMed General Information

Description

Developer of surgical tools based in Kansas, United States. The company specializes in producing a cautery tool for common gynecologic surgery purposes, enabling healthcare professionals with precise control over the cutting and coagulation of tissues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Surgical Devices
Primary Office
  • 257 South Holyoke Street
  • Wichita, KS 67218
  • United States
+1 (563) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RayMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 10-Oct-2016 $300K 00000 Completed Startup
1. Grant 0000 Completed Startup
To view RayMed’s complete valuation and funding history, request access »

RayMed Patents

RayMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170007356-A1 Manual electrocautery device Inactive 07-Jul-2015 000000000 0
US-20170007315-A1 Manual electrocautery device Inactive 07-Jul-2015 00000000000 0

RayMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RayMed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kansas Board of Regents Government 000 0000 000000 0
To view RayMed’s complete investors history, request access »